Patent · US Active

Binding proteins and chimeric antigen receptor T cells targeting GASP-1 granules and uses thereof

US12110340B2 · kind B2 · utility

0Cited by
4References
45Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2019
Grant dateOct 8, 2024
Priority date
Expiry dateOct 13, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for detecting cells having granules expressing G protein coupled receptor-associated sorting protein 1 (GASP-1) or a fragment thereof is provided. The detection method may comprise: (a) contacting the cells with an effective amount of a binding protein, wherein the binding protein comprises an antigen binding fragment that specifically binds GASP-1; and (b) identifying cells having granules bound to the binding protein. The GASP-1 granules may be in the cytosol or on the surface of the cells. Also provided are methods for producing T-cells comprising a chimeric antigen receptor, anti-GASP-1 antibody or a bi-specific binding protein. Further provided are methods for treating GASP-1-mediated to disease or inactivating exosomes, microvesicles or oncosomes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.